Pharma Equity Group A/S — Credit Rating and Financial Key Figures
CVR number: 26791413
Slotsmarken 18, 2970 Hørsholm
info@pharmaequitygroup.com
tel: 32548800
www.pharmaequitygroup.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | |||||
Costs of management | -2 135.00 | -5 780.00 | -11 809.00 | -12 285.00 | |
Other operating expenses | 4 906.00 | -5 497.00 | -8 820.00 | -9 002.00 | |
EBIT | -2 135.00 | 4 906.00 | -11 277.00 | -20 629.00 | -21 287.00 |
Other financial income | 1 151.00 | 14.00 | 14.00 | ||
Other financial expenses | - 272.00 | - 665.00 | -22.00 | -1 562.00 | -4 964.00 |
Pre-tax profit | -32 875.00 | 5 392.00 | -11 299.00 | -26 580.00 | -26 237.00 |
Income taxes | 1 855.00 | 2 233.00 | 1 815.00 | ||
Net earnings | -32 875.00 | 5 392.00 | -9 444.00 | -24 347.00 | -24 422.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible rights | 13 860.00 | ||||
Intangible assets total | 13 860.00 | ||||
Other tangible assets | 582.00 | 55.00 | 37.00 | ||
Tangible assets total | 582.00 | 55.00 | 37.00 | ||
Other non-current investments | 63 500.00 | - 802.00 | -1 893.00 | - 238.00 | |
Investments total | 63 500.00 | - 802.00 | -1 893.00 | - 238.00 | |
Non-curr. owed by particip. interest comp. | 57 500.00 | ||||
Non-current other receivables | 802.00 | 2 344.00 | 472.00 | ||
Long term receivables total | 57 500.00 | 802.00 | 2 344.00 | 472.00 | |
Inventories total | |||||
Current trade debtors | 82.00 | 137.00 | |||
Prepayments and accrued income | 8.00 | 1 587.00 | 423.00 | 813.00 | |
Current other receivables | 802.00 | 60 344.00 | 58 473.00 | ||
Current deferred tax assets | 1 855.00 | 2 233.00 | 1 815.00 | ||
Short term receivables total | 82.00 | 145.00 | 4 244.00 | 63 000.00 | 61 101.00 |
Cash and bank deposits | 2 830.00 | 4 231.00 | 4 234.00 | ||
Cash and cash equivalents | 2 830.00 | 4 231.00 | 4 234.00 | ||
Balance sheet total (assets) | 57 582.00 | 63 645.00 | 21 516.00 | 67 737.00 | 65 606.00 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 83 092.00 | 18 655.00 | 830.00 | 1 022 964.00 | 122 756.00 |
Other reserves | 4 220.00 | - 997 631.00 | -73 881.00 | ||
Retained earnings | -15 936.00 | 18 519.00 | 9 444.00 | 24 347.00 | 24 422.00 |
Profit of the financial year | -32 875.00 | 5 392.00 | -9 444.00 | -24 347.00 | -24 422.00 |
Shareholders equity total | 34 281.00 | 42 566.00 | 5 050.00 | 25 333.00 | 48 875.00 |
Non-current loans from credit institutions | 6 582.00 | ||||
Non-current leasing loans | 295.00 | 234.00 | |||
Non-current other liabilities | 7 838.00 | 8 100.00 | |||
Non-current liabilities total | 6 582.00 | 295.00 | 8 072.00 | 8 100.00 | |
Current loans from credit institutions | 8 479.00 | 9 036.00 | |||
Current leasing loans | 286.00 | 217.00 | 234.00 | ||
Current trade creditors | 3 260.00 | 654.00 | |||
Other non-interest bearing current liabilities | 1 562.00 | 3 307.00 | 2 024.00 | 34 115.00 | 8 397.00 |
Current provisions | 10 000.00 | 1 500.00 | |||
Current liabilities total | 23 301.00 | 14 497.00 | 2 310.00 | 34 332.00 | 8 631.00 |
Balance sheet total (liabilities) | 57 582.00 | 63 645.00 | 7 655.00 | 67 737.00 | 65 606.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.